Chemed (NYSE:CHE) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

CHE Panoramica delle azioni

CHE analisi fondamentale
Punteggio fiocco di neve
Valutazione	1/6
Crescita futura	1/6
Prestazioni passate	6/6
Salute finanziaria	6/6
Dividendi	0/6

Premi

Si prevede che gli utili cresceranno del 13.25% all'anno

Gli utili sono cresciuti del 32.9% nell'ultimo anno

Analisi del rischio

Importanti vendite da parte di insider negli ultimi 3 mesi

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Strategic Acquisitions And Operational Efficiencies Set To Propel VITAS And Roto-Rooter Forward

US$685.00

12.5% undervalued

7.20%

Revenue growth p.a.

21 days ago

Chemed Corporation Concorrenti

DaVita

NYSE:DVA

US$13.7b

CorVel

NasdaqGS:CRVL

US$5.5b

Option Care Health

NasdaqGS:OPCH

US$5.4b

Quest Diagnostics

NYSE:DGX

US$17.2b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Chemed
Prezzi storici delle azioni
Prezzo attuale dell'azione	US$599.04
Massimo di 52 settimane	US$654.62
Minimo di 52 settimane	US$497.37
Beta	0.44
1Variazione di 1 mese	2.20%
Variazione a 3 mesi	11.03%
Variazione di 1 anno	15.27%
3Variazione a 3 anni	30.85%
Variazione a 5 anni	45.23%
Variazione dall'IPO	5,195.38%

Notizie e aggiornamenti recenti

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26

Recent updates

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16

Rendimenti per gli azionisti

	CHE	US Healthcare	US Mercato
7D	2.9%	0.3%	0.9%
1Y	15.3%	12.0%	32.3%

Ritorno vs Industria: CHE ha superato il US Healthcare che ha restituito 12.3 % nell'ultimo anno.

Rendimento vs Mercato: CHE ha avuto una performance inferiore al mercato US che ha registrato un rendimento 25.6 % nell'ultimo anno.

Volatilità dei prezzi

Is CHE's price volatile compared to industry and market?
CHE volatility
CHE Average Weekly Movement	2.5%
Healthcare Industry Average Movement	7.0%
Market Average Movement	6.4%
10% most volatile stocks in US Market	14.8%
10% least volatile stocks in US Market	3.2%

Prezzo delle azioni stabile: CHE non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 3% ) di CHE è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1970	15,087	Kevin McNamara	www.chemed.com

Chemed Corporation fornisce servizi di hospice e cure palliative ai pazienti attraverso una rete di medici, infermieri registrati, assistenti sanitari a domicilio, operatori sociali, clero e volontari, principalmente negli Stati Uniti. L'azienda opera nei segmenti VITAS e Roto-Rooter. Offre servizi idraulici, di pulizia degli scarichi, di scavo, di risanamento delle acque e altri servizi correlati a clienti privati e commerciali attraverso filiali di proprietà dell'azienda, appaltatori indipendenti e franchisee.

Chemed Corporation Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Chemed con la sua capitalizzazione di mercato?
CHE statistiche fondamentali
Capitalizzazione di mercato	US$8.98b
Guadagni(TTM)	US$300.92m
Ricavi(TTM)	US$2.34b

29.9x

Rapporto P/E

3.8x

Rapporto P/S

CHE è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
CHE Conto economico (TTM)
Ricavi	US$2.34b
Costo del fatturato	US$1.50b
Profitto lordo	US$839.98m
Altre spese	US$539.06m
Guadagni	US$300.92m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

Oct 29, 2024

Utile per azione (EPS)	20.07
Margine lordo	35.96%
Margine di profitto netto	12.88%
Rapporto debito/patrimonio netto	0%

Come si è comportato CHE nel lungo periodo?

Vedi performance storica e confronto

Dividendi

0.3%

Rendimento attuale del dividendo

8%

Rapporto di remunerazione

CHE Panoramica delle azioni

Premi

Analisi del rischio

Strategic Acquisitions And Operational Efficiencies Set To Propel VITAS And Roto-Rooter Forward

Chemed Corporation Concorrenti

NYSE:DVA

US$13.7b

NasdaqGS:CRVL

US$5.5b

NasdaqGS:OPCH

US$5.4b

NYSE:DGX

US$17.2b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

CEO, President & Director recently sold US$1.2m worth of stock

Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024

Executive Vice President recently sold US$975k worth of stock

Executive Vice President exercised options and sold US$1.6m worth of stock

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Recent updates

CEO, President & Director recently sold US$1.2m worth of stock

Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024

Executive Vice President recently sold US$975k worth of stock

Executive Vice President exercised options and sold US$1.6m worth of stock

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Remains A Buy On Long-Term Economics

VP & Director notifies of intention to sell stock

Second quarter dividend increased to US$0.50

Chemed Corporation Declares Quarterly Dividend, Payable on August 30, 2024

Executive Vice President recently sold US$1.1m worth of stock

Executive Vice President notifies of intention to sell stock

Second quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed Corporation to Report Q2, 2024 Results on Jul 24, 2024

CEO, President & Director recently sold US$816k worth of stock

CEO, President & Director notifies of intention to sell stock

First quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on June 18, 2024

Chemed: Growth Does Not Justify The Current Stock Price

CEO, President & Director recently sold US$2.3m worth of stock

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation Reiterates Earnings Guidance for Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation, Annual General Meeting, May 20, 2024

New major risk - Revenue and earnings growth

Executive Vice President exercised options and sold US$3.8m worth of stock

Executive Vice President recently sold US$1.3m worth of stock

Chemed Corporation to Report Q1, 2024 Results on Apr 24, 2024

Price target increased by 10% to US$690

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 22% overvalued after recent price rise

Third quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on March 15, 2024

Chemed Corporation to Report Q4, 2023 Results on Feb 27, 2024

The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed Corporation Appoints Michael D. Witzeman as Chief Financial Officer, Effective January 1, 2024

CEO, President & Director recently sold US$859k worth of stock

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Executive Vice President recently sold US$580k worth of stock

Executive VP & CFO notifies of intention to sell stock

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Executive VP & CFO exercised options to buy US$5.9m worth of stock.

CEO, President & Director recently sold US$1.7m worth of stock

Chemed Corporation Provides Earnings Guidance for the Full-Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Corporation to Report Q3, 2023 Results on Oct 25, 2023

Chemed - Showcasing Why It's So Reliable

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

CEO, President & Director recently sold US$2.1m worth of stock

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Corporation to Report Q2, 2023 Results on Jul 26, 2023

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Executive Vice President notifies of intention to sell stock